MedTrace Logo

Reducing Fall Risk With NMES

NCT04969094 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2026-03-30

No results posted yet for this study

Summary

Falls are dangerous leading to injuries, hospital admissions and even death. Fall prevention is a priority but effective programs only reduce falls by 30%. Weak hip muscles may be one reasons individuals experience a loss of balance. However individuals who have weak hip muscles may be unable to exercise at sufficient intensities to improve their hip muscle strength. The purpose of this study is to utilize a common physical therapy method, neuromuscular electrical stimulation (NMES), on the hip muscles to improve hip muscle strength and improve balance. The new program focuses on using NMES during a resistance training program along with exercise to improve standing balance, walking and stepping over objects. This study will test the additive effect of NMES applied to the hip muscles during a balance and strengthening program to improve balance and mobility, and ultimately reduce the risk of falls in older Veterans at high risk for falls.

Conditions

  • Falls

Interventions

OTHER

Neuromuscular electrical stimulation (NMES)

Participants will receive NMES to the hip abductors while performing strength training 3 times per week for 3-months

OTHER

Multi-Modality Balance Intervention (MMBI)

Participants will attend a group balance class that focuses on movement and obstacle negotiation 3 times per week for 3-months

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Odessa R. Addison, PhD DPT · Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-04
Primary Completion
2026-01-30
Completion
2027-01-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969094 on ClinicalTrials.gov